Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection
Open Access
- 1 January 2014
- journal article
- research article
- Published by Informa UK Limited in International Journal of Nanomedicine
- Vol. 9, 327-36
- https://doi.org/10.2147/ijn.s54967
Abstract
Peer reviewed article authored by (Yang Z, Chen M, Yang M, Chen J, Fang W, Xu P). Read article or submit your manuscript for publishing.Keywords
This publication has 34 references indexed in Scilit:
- Comparison of the Permeability of Metoprolol and Labetalol in Rat, Mouse, and Caco-2 Cells: Use as a Reference Standard for BCS ClassificationMolecular Pharmaceutics, 2013
- Lamellar Liquid Crystalline Phases for Cutaneous Delivery of Paclitaxel: Impact of the MonoglyceridePharmaceutical Research, 2012
- Morphological observations on a lipid-based drug delivery system during in vitro digestionEuropean Journal of Pharmaceutical Sciences, 2007
- Drug Release from Differently Structured Monoolein/Poloxamer Nanodispersions Studied with Differential Pulse Polarography and Ultrafiltration at Low PressureJournal of Pharmaceutical Sciences, 2007
- Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin DeliveryBiomacromolecules, 2006
- New Formulations and Derivatives of Amphotericin B for Treatment of LeishmaniasisMini-Reviews in Medicinal Chemistry, 2006
- Amphotericin B cochleates: a vehicle for oral delivery.2004
- Potential Mechanisms by Which Peceol® Increases the Gastrointestinal Absorption of Amphotericin BDrug Development and Industrial Pharmacy, 2004
- Effects of Lipid-Based Oral Formulations on Plasma and Tissue Amphotericin B Concentrations and Renal Toxicity in Male RatsAntimicrobial Agents and Chemotherapy, 2003
- Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.Pharmaceutical Research, 1998